Literature DB >> 12392055

Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection.

Martin B Wax1, Gülgün Tezel.   

Abstract

Although glaucomatous optic nerve degeneration is a leading cause of worldwide blindness, neither the precise cellular mechanisms underlying neurodegeneration in glaucoma, nor effective strategies for neuroprotection are yet clear. This review focuses on diverse cellular events associated with glaucomatous neurodegeneration whose balance is critical for determination of ultimate cell fate. An improved understanding of the site of primary injury to optic nerve, the mediator pathways of apoptotic cell death and intrinsic protection mechanisms in retinal ganglion cells, the role of glial activation on the survival and death of retinal ganglion cell bodies and their axons, and the protective and destructive consequences of immune system involvement can facilitate development of effective neuroprotective strategies in glaucoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392055     DOI: 10.1385/MN:26:1:045

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  102 in total

Review 1.  Heat-shock proteins: immunity and autoimmunity.

Authors:  D B Young
Journal:  Curr Opin Immunol       Date:  1992-08       Impact factor: 7.486

2.  Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

Authors:  X Liu; C N Kim; J Yang; R Jemmerson; X Wang
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 5.  Pattern of visual field defects in normal-tension and high-tension glaucoma.

Authors:  M Araie
Journal:  Curr Opin Ophthalmol       Date:  1995-04       Impact factor: 3.761

6.  An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma.

Authors:  X Wang; S S Tay; Y K Ng
Journal:  Exp Brain Res       Date:  2000-06       Impact factor: 1.972

Review 7.  Signalling by CD95 and TNF receptors: not only life and death.

Authors:  C Magnusson; D L Vaux
Journal:  Immunol Cell Biol       Date:  1999-02       Impact factor: 5.126

8.  Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma.

Authors:  M B Wax; G Tezel; P D Edward
Journal:  Arch Ophthalmol       Date:  1998-08

9.  A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema.

Authors:  D S Minckler; M O Tso; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1976-11       Impact factor: 5.258

10.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  30 in total

1.  Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Yong Peng; Sheher L Sun; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

2.  Hypoxia Activates Calpains in the Nerve Fiber Layer of Monkey Retinal Explants.

Authors:  Masayuki Hirata; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

3.  High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.

Authors:  Michael G Anderson; Richard T Libby; Douglas B Gould; Richard S Smith; Simon W M John
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-09       Impact factor: 11.205

4.  Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D: -aspartate-induced intracellular Ca(2+) increase.

Authors:  A Matteucci; C Frank; M R Domenici; M Balduzzi; S Paradisi; G Carnovale-Scalzo; G Scorcia; F Malchiodi-Albedi
Journal:  Exp Brain Res       Date:  2005-08-03       Impact factor: 1.972

5.  Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.

Authors:  Kelvin Yoon Chiang Lee; Mao Nakayama; Makoto Aihara; Yi-Ning Chen; Makoto Araie
Journal:  Mol Vis       Date:  2010-02-17       Impact factor: 2.367

6.  Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.

Authors:  Molly M Walsh; Haiqing Yi; Julie Friedman; Kyoung-In Cho; Nomingerel Tserentsoodol; Stuart McKinnon; Kelly Searle; Andrew Yeh; Paulo A Ferreira
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

Review 7.  Primary open-angle glaucoma.

Authors:  Young H Kwon; John H Fingert; Markus H Kuehn; Wallace L M Alward
Journal:  N Engl J Med       Date:  2009-03-12       Impact factor: 91.245

8.  Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress.

Authors:  Nariko Miyara; Manabu Shinzato; Yoshito Yamashiro; Akihiro Iwamatsu; Ken-Ichi Kariya; Shoichi Sawaguchi
Journal:  Jpn J Ophthalmol       Date:  2008-04-30       Impact factor: 2.447

9.  Erratum: The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-09-09

10.  The two sides of cytokine signaling and glaucomatous optic neuropathy.

Authors:  Ping Huang; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Ocul Biol Dis Infor       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.